Trial Profile
A Retrospective Study of OK-432 in Patient with Lymphatic Malformation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Picibanil (Primary)
- Indications Lymphangioma
- Focus Therapeutic Use
- 10 May 2018 New trial record